Overview

Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of Cardene I.V. to labetalol administered intravenously for the management of hypertension in the emergency department setting.
Phase:
Phase 4
Details
Lead Sponsor:
The Cleveland Clinic
Collaborator:
EKR Therapeutics, Inc
Treatments:
Labetalol
Nicardipine